Quantcast

Latest Serono Stories

2014-07-23 08:31:39

BOSTON, July 23, 2014 /PRNewswire/ -- The management team at Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call on July 31, 2014, to discuss financial results for the second quarter ended June 30, 2014. The call details are as follows: Date: Thursday, July 31, 2014 Time: 8:30 am EDT Dial-in numbers: Toll free: (877) 870-4263 (U.S.), (855) 669-9657 (Canada) or, International: (412)...

2014-07-21 12:25:25

PORTLAND, Oregon, July 21, 2014 /PRNewswire/ -- A new report by Allied Market Research titled, "Global biosimilars/follow-on-biologics market (types, applications and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that the global biosimilars market would reach $35 billion by 2020 from the estimated $1.3 billion in 2013. Deeper penetration with clearer...

2014-07-16 12:27:18

MADRID, July 16, 2014 /PRNewswire/ -- Biospain 2014 is currently seeking and selecting projects for presentation as part of its Investment Forum, one of the most high profile in the sector, for which 25 investment funds - 70% of which are international- have already confirmed their attendance, a figure the organisers expect to double. (Logo: http://photos.prnewswire.com/prnh/20140716/697032 ) This year the Forum will be bolstered by the presence of a wider...

2014-07-01 08:31:08

- Investment reflects company's ongoing commitment to innovation in fertility research ROCKLAND, Mass., July 1, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced its strong support of the Grant for Fertility Innovation (GFI) fund with grants totaling up to EUR 2 million for the years 2014/2015. The announcement was made during the 30(th) annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) currently taking...

2014-06-24 08:30:07

- Collaboration and license agreement allows Merck Serono to expand its oncology drug portfolio ROCKLAND, Mass., June 24, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Mersana Therapeutics, Inc., Cambridge, Mass., U.S., announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs). ADCs are composed of an antibody linked to cytotoxic drugs, whereby the antibody part specifically targets and...

2014-06-19 16:25:45

DUBAI, United Arab Emirates, June 19, 2014 /PRNewswire/ -- Advancing an imperative global discussion on pharma development in the Middle East and North Africa, Marwan Abdulaziz Janahi, Executive Director of TECOM Investments' Science Cluster in Dubai will participate in a panel discussion at The BIO International Convention (BIO 2014). Titled "Healthcare Competitiveness and New Opportunities for R&D in the Middle East and North Africa", the panel will be held on Wednesday, June 25, 2014...

2014-06-11 08:30:55

ROCKLAND, Mass., June 11, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany announced today its commitment to U.S. military veterans and their spouses with the introduction of the Compassionate Corps Program. Through the program, veterans and their spouses may be eligible to receive free fertility medicine. To view the multimedia assets associated with this release, please click:...

2014-06-04 16:25:48

BOSTON, June 4, 2014 /PRNewswire/ -- Since 1987, Massachusetts has led the New England region with its comprehensive legislative mandate that requires insurance coverage for the diagnosis and treatment of infertility. On June 11, 2014, RESOLVE New England will host a Massachusetts State Advocacy Day that will celebrate the advances in reproductive technology and health coverage that have helped create tens of thousands of new families in Massachusetts. The State Advocacy Day will...

2014-05-29 04:21:52

ROCKLAND, Massachusetts, May 29, 2014 /PRNewswire/ -- ASCO abstract #: Anti-PD-L1: 3064; c-Met: 2521, TPS4151, TPS8121; tecemotide: TPS3658, TPS7608; TH-302: 8534, 2029; further pipeline: 3551, TPS9107, 5030, 2050, e13552 - Robust pipeline reflects commitment to innovation in oncology and immuno-oncology - Data from nine EMD Serono pipeline products across oncology and immuno-oncology to be presented, including anti-PD-L1, c-Met...

2014-05-28 08:33:20

ROCKLAND, Mass., May 28, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Rebif(®) (interferon beta-1a) data will be presented at the 2014 Cooperative Meeting of CMSC (Consortium of Multiple Sclerosis Centers) and ACTRIMS (Americas Committee on Research & Treatment in Multiple Sclerosis), taking place from May 28 - 31, in Dallas, TX. http://photos.prnewswire.com/prnvar/20121220/SF32295LOGO-b Data from 11 study assessments will...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related